How Alzheimer's Disease Affects C/EBPδ Regulation
Author Information
Author(s): Veronica Ramberg, Linda M Tracy, Malin Samuelsson, Lars NG Nilsson, Kerstin Iverfeldt
Primary Institution: Department of Neurochemistry, Stockholm University
Hypothesis
Different aggregation states of amyloid-β affect the regulation of C/EBPδ during inflammatory conditions in Alzheimer's disease.
Conclusion
The study suggests that both expression and function of C/EBPδ are dysregulated in Alzheimer's disease due to the presence of amyloid-β fibrils.
Supporting Evidence
- Fibril-enriched Aβ preparations significantly down-regulated C/EBPδ levels in activated astro-microglial cultures.
- C/EBPδ levels were decreased by ~62% in the forebrain of aged tg-ArcSwe mice compared to non-transgenic mice.
- IL-1β-induced C/EBPδ binding activity was abolished after exposure to Aβ fibrils.
- Different aggregation states of Aβ affect C/EBPδ function rather than its expression levels.
Takeaway
In Alzheimer's disease, a protein called C/EBPδ doesn't work properly because of a sticky substance in the brain called amyloid-β. This can make inflammation worse.
Methodology
The study used rat primary astro-microglial cultures and a transgenic mouse model to analyze the effects of amyloid-β on C/EBPδ expression and function.
Potential Biases
Potential bias in the interpretation of results due to reliance on specific experimental models.
Limitations
The study primarily focuses on specific models and may not fully represent all aspects of Alzheimer's disease pathology.
Participant Demographics
Aged transgenic mice and male Sprague Dawley pups were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website